Advisory Board and Editors Pharmacology
Mohd Adnan
Prof. Dr. Mohd Adnan is a Principal Investigator and Head of Academic Committee at Department of Biology, College of Science, University of Ha'il, Saudi Arabia. He did his PhD from University of Central Lancashire, UK; Master’s and Bachelor’s degree from Bangalore University, India; Post Graduate Diploma in Bioinformatics from SJAIT, India. He has more than 14 years of research, teaching and administrative experience. In his professional capacity, he has received various travel, observership and research grants as a Principal Investigator from various prestigious organizations.
He has successfully published 250+ publications in internationally recognized peer reviewed reputed journals, several book chapters for internationally renowned publishers and presented many papers and posters in various conferences/workshops globally. He has published widely in the field of phytomedicine, biofilms, drug discovery, natural products, nutraceuticals and functional foods with specialization in plant-based antibiofilm and anticancer agents, microbial biosurfactants, biofilms in food industry and medical settings, probiotics and cancer biology, novel biomolecules for/as health and antimicrobial agents.
He has reviewed 400+ manuscripts for 70+ internationally recognized peer-reviewed JCR journals and grant reviewer for many prestigious universities and organisations. In addition, he is a member of SFAM, UK and ESCMID, Switzerland and an Elected Member of Royal Society of Biology, UK. He also currently holds different editorial positions (Associate, Academic, Guest and Review Editor) in various esteemed journals and has edited 500+ manuscripts.
Abdulaziz I Alzarea
Dr. Abdulaziz Alzarea holds doctorate in Pharmaceutical Economics and Policy (Health Economics and Outcomes Research) and is currently serving as head of the Department of Clinical Pharmacy in Jouf University, Saudi Arabia. He has broad experience in Publishing related to Clinical Pharmacy, Pharmacy Practice, Pharmacoeconomics, Pharmacoepidemiology and outcomes research.
Davide Barreca
Davide Barreca is an Associate Professor of biochemistry at the University of Messina. He is specialized in enzyme modulation by natural compounds, inhibition of protein aggregation and activation of signal apoptotic cascade. Most of his research projects concentrate on separation and identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of their health promoting or cytotoxicity properties on cells culture. He is author of over 110 papers in peer-reviewed journals, 35 chapters in books, and 70 conference proceedings and reviewer of over 40 international scientific journals.
Glen M Borchert
Dr. Glen Borchert holds joint appointments as an Assistant Professor in Biology and Pharmacology at the University of South Alabama. He originally received a B.S. in Biology from the University of Tennessee then completed a Ph.D. in Genetics from the University of Iowa. Dr. Borchert’s research focuses largely on identifying novel genetic regulators and defining their roles in oncogenesis, microbiology and speciation. Since starting his laboratory at South Alabama in August 2012, Dr. Borchert has published dozens of papers in peer reviewed journals and had numerous grant applications funded including a highly prestigious NSF CAREER award (2014-2019).
Minjun Chen
Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.
Olivier Civelli
Chair and Professor, Pharmacology and Eric L. and Lila D. Nelson Chair in Neuropharmacology, School of Medicine, University of California, Irvine.
Mark Connor
Professor of Pharmacology in the Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University. I study the cellular basis of opioid and cannabinoid receptor/ligand actions, with with the aim of better understanding their acute effects and the adaptations that occur after prolonged administration. This work has taken me to the University of Washington, University of Bristol, University of Sydney and the Vollum Institute before arriving at Macquarie. At the moment my lab focuses on the pharmacology of illicit synthetic cannabinoids and the molecular effects of phytocannabinoids.
Christopher Cooper
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Leticia Costa-Lotufo
Dr. Costa-Lotufo is a full professor at the Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo. Her lab is focused on the discovery of new anticancer compounds from Brazilian marine biodiversity and studies on their mechanisms of action. She coordinate a multidisciplinary project to access marine microorganisms diversity and biotechnological potential along the Brazilian coast and islands. Dr. Costa-Lotufo’s activities include the supervision of undergraduate and graduate students and post-doctoral fellows. She has published book chapters, review articles and more than 230 articles in peer-reviewed journals. On 2010, Dr. Costa-Lotufo was nominated as a young scientist of the Brazilian Academy of Science (2010-2014).
Anissa Daliry
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). Her main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases.
Alberto Davalos
Group leader of the Epigenetics of Lipid Metabolism Group, IMDEA Food Institute, Dr. Alberto Dávalos holds a degree in Pharmacy and Biochemistry by San Marcos University (Lima) and a PhD in Pharmacy by Universidad Complutense de Madrid (Madrid).
He has conducted postdoctoral research at the Hospital Ramón y Cajal (Madrid), at Yale University School of Medicine, (New Haven), and at New York University School of Medicine (New York). Dr. Dávalos’s research program focuses in identifying and characterizing new noncoding RNAs (miRNAs, lncRNAs and other type of regulatory RNAs) that regulate lipid metabolism and the effects of minor dietary components (micronutrients) on their expression.
Renan Pedra de Souza
Dr. Renan Souza is Associate Professor of Genetics at the Universidade Federal de Minas Gerais, Brazil.
His research interests include Genetics, Pharmacology, Personalized Medicine and Molecular Epidemiology.